FDA's Lack Of Power May Limit FTC's Patent Challenge
The Federal Trade Commission's challenge to more than 100 pharmaceutical patents builds on the agency's close attention to factors impacting drug pricing, but it may not have any immediate force given...To view the full article, register now.
Already a subscriber? Click here to view full article